The life sciences industry is in the middle of a significant construction boom, partly fueled by research and manufacturing of vaccines and therapies to fight the COVID-19 virus and its variants. There are hundreds of new projects under construction, in various stages of planning or just completed. The developments run the gamut from production facilities to office space to laboratories for...
Microbial quality encompasses sterility assurance—and more, as discussed by Joyce Hansen, Vice President of J&J Microbiological Quality and Sterility Assurance at Johnson & Johnson in the keynote at the Plenary Session, “Microbiology Quality and Cultivating Emerging Leaders” that kicked off Day 2 of the 2022 ISPE Aseptic Conference.
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from February 2022. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.
The 2022 ISPE Aseptic Conference opened on Monday 14 March with keynote presentations by two regulators focusing respectively on PIC/S harmonization efforts (including the forthcoming Annex 1 revision) and FDA...
This article describes an amazing story of self-sufficiency: how Thailand has managed to develop six different Covid 19 vaccines in a very short time. This story describes how the Thai Government, The Royal Family, the Universities and private companies are working together to benefit the nation, three of these are using new technology developed in Thailand.
